Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001140361-13-037701
Filing Date
2013-10-03
Accepted
2013-10-03 12:40:26
Documents
2
Group Members
INTREXON CORPNRM VII HOLDINGS I, LLCTHIRD SECURITY, LLC

Document Format Files

Seq Description Document Type Size
1 RANDAL J KIRK SC 13DA NO 2 10-1-2013 (FIBROCELL) formsc13da.htm SC 13D/A 107033
2 EXHIBIT 1 ex1.htm EX-1 8919
  Complete submission text file 0001140361-13-037701.txt   117567
Mailing Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341 484-713-6000
Fibrocell Science, Inc. (Subject) CIK: 0000357097 (see all company filings)

EIN.: 870458888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-60307 | Film No.: 131132804
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1881 GROVE AVENUE RADFORD VA 24141
Business Address
KIRK RANDAL J (Filed by) CIK: 0001091823 (see all company filings)

Type: SC 13D/A